Aurinia Pharmaceuticals Inc
NASDAQ:AUPH

Watchlist Manager
Aurinia Pharmaceuticals Inc Logo
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Watchlist
Price: 8.945 USD 2% Market Closed
Market Cap: 1.3B USD
Have any thoughts about
Aurinia Pharmaceuticals Inc?
Write Note

Wall Street
Price Targets

AUPH Price Targets Summary
Aurinia Pharmaceuticals Inc

Wall Street analysts forecast AUPH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AUPH is 11.052 USD with a low forecast of 8.08 USD and a high forecast of 13.65 USD.

Lowest
Price Target
8.08 USD
10% Downside
Average
Price Target
11.052 USD
24% Upside
Highest
Price Target
13.65 USD
53% Upside

AUPH Last Price Targets
Aurinia Pharmaceuticals Inc

The latest public price target was made on Sep 6, 2024 by Ed Arce from H.C. Wainwright , who expects AUPH stock to rise by 45% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Ed Arce
H.C. Wainwright
13 USD
Upside 45%
2 months ago
Sep 6, 2024
H.C. Wainwright Reiterates Buy Rating on Aurinia Pharmaceuticals (AUPH)
StreetInsider
Maury Raycroft
Jefferies
6 USD
Downside 33%
6 months ago
May 2, 2024
Aurinia Pharmaceuticals (AUPH) PT Lowered to $6 at Jefferies
StreetInsider
Ed Arce
H.C. Wainwright
Price Target 13 USD
Upside/Downside 45%
View Source
Maury Raycroft
Jefferies
Price Target 6 USD
Upside/Downside 33%
View Source
Aurinia Pharmaceuticals Inc Competitors:
Price Targets
NANO
Nanobiotix SA
252% Upside
MIRM
Mirum Pharmaceuticals Inc
43% Upside
KOD
Kodiak Sciences Inc
27% Downside
VYGR
Voyager Therapeutics Inc
211% Upside
301301
Yili Chuanning Biotechnology Co Ltd
17% Downside
MOLN
Molecular Partners AG
133% Upside
PTCT
PTC Therapeutics Inc
6% Upside
603392
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
14% Downside

Revenue
Forecast

Revenue Estimate
Aurinia Pharmaceuticals Inc

For the last 8 years the compound annual growth rate for Aurinia Pharmaceuticals Inc's revenue is 133%. The projected CAGR for the next 3 years is 26%.

133%
Past Growth
26%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Aurinia Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Aurinia Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-25%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AUPH's stock price target?
Price Target
11.052 USD

According to Wall Street analysts, the average 1-year price target for AUPH is 11.052 USD with a low forecast of 8.08 USD and a high forecast of 13.65 USD.

What is Aurinia Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
26%

For the last 8 years the compound annual growth rate for Aurinia Pharmaceuticals Inc's revenue is 133%. The projected CAGR for the next 3 years is 26%.

Back to Top